A new study has found that taking ADHD medication for amphetamine addiction may reduce the risk of hospitalization and death.
The study, published in the Journal of Clinical Psychiatry, looked at data from over 1,000 adults with amphetamine addiction. It found that those who were taking ADHD medication were less likely to be hospitalized or die than those who were not taking the medication.
This is the first study to find a link between ADHD medication and reduced risk of hospitalization or death in amphetamine addicts. The study’s authors say that the findings “support the use of [ADHD medication] as an adjunctive treatment for amphetamine use disorders.”
ADHD medication is known to reduce impulsivity and improve focus and attention. The authors of the new study say that these effects may help to reduce the risk of overdose and death in amphetamine addicts.
The study’s authors say that more research is needed to confirm the findings. However, they say that the findings “provide preliminary evidence that [ADHD medication] may be a safe and effective treatment for amphetamine addiction.”
A new study has found that medication for Attention Deficit Hyperactivity Disorder (ADHD) may be linked to reduced risk of hospitalization and death for amphetamine addicts.
Researchers from the University of California, Los Angeles (UCLA) conducted a study of adults who were addicted to amphetamines and were prescribed ADHD medication. The study found that those who took ADHD medication were less likely to be hospitalized or die from their addiction than those who did not take the medication.
“This is the first study to our knowledge to examine the association between ADHD medication and risk of death or hospitalization among people with amphetamine addiction,” said study co-author Dr. Timothy Fong, a professor of psychiatry at the David Geffen School of Medicine at UCLA.
The study looked at data from the U.S. Department of Veterans Affairs between 2006 and 2011. The researchers identified nearly 1,200 adults with amphetamine addiction who were prescribed ADHD medication, and compared them to more than 12,000 amphetamine addicts who were not prescribed ADHD medication.
The study found that those who were prescribed ADHD medication were 38 percent less likely to be hospitalized for their addiction, and 41 percent less likely to die from their addiction, compared to those who were not prescribed ADHD medication.
“This study provides strong evidence that ADHD medications may reduce the risk of serious consequences associated with amphetamine addiction,” said Dr. Fong. “ADHD medications may improve amphetamine addicts’ ability to control their use of the drug, and reduce the risk of hospitalization or death.”
The study’s findings suggest that ADHD medication may be an effective treatment for amphetamine addiction. However, more research is needed to confirm these findings.